Chiron
Executive Summary
Company plans to sell St. Louis, Mo. recombinant protein manufacturing facility. Production will stop by June and the 60 employees at the site will be let go, Chiron says. Products produced at the facility will be manufactured at Chiron's Emeryville, CA, Siena, Italy and Marburg, Germany facilities, the company says...